{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:29:27Z","timestamp":1787020167615,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many clinical guidelines recommend FDG PET\/CT for the evaluation of pulmonary nodules \u22658\u2009mm detected during low dose computed tomography (LDCT) lung cancer screening. However, its added value in this setting requires confirmation. We evaluated the clinical utility of FDG PET\/CT, including incidental findings, during the evaluation of lung nodules detected on LDCT screening.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A retrospective cohort study was performed among 75 patients who completed FDG PET\/CT between January 2010 and December 2017, after lung nodules\n                      <jats:underline>&gt;<\/jats:underline>\n                      \u20098\u2009mm had been detected on LDCT lung cancer screening. We report demographic variables, characteristics of the initial nodules on LDCT and FDG PET\/CT, incidental findings on FDG PET\/CT, as well as further work up performed and the influence of FDG PET\/CT findings on management.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nodules were reported to be benign on FDG PET\/CT in 38\/75 (50.6%) patients. Physicians chose either radiological follow-up or no further work up in all 38. FDG PET\/CT was indeterminate or suggested malignancy in 37 (49.3%) patients. Biopsy was performed in 32 (86%) of these patients. Incidental findings on FDG PET\/CT were reported in 37\/75 (49%) patients. Further work-up of incidental findings was performed in 21\/75 (28%) of patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study, for majority of individuals with lung nodules identified during LDCT lung cancer screening, FDG PET\/CT results were able to guide physicians in choosing between routine follow up or invasive biopsies. Conversely, 28% of these patients required additional investigations to address incidental findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12880-020-00469-0","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T07:03:02Z","timestamp":1592809382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Utility of FDG PET\/CT for assessment of lung nodules identified during low dose computed tomography screening"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3140-4529","authenticated-orcid":false,"given":"Sarah","family":"Hadique","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranav","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousaf","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneeqah","family":"Baig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"issue":"5","key":"469_CR1","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/NEJMoa1102873","volume":"365","author":"Team NLSTR","year":"2011","unstructured":"Team NLSTR. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395\u2013409.","journal-title":"N Engl J Med"},{"issue":"5","key":"469_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7326\/M13-2771","volume":"160","author":"VA Moyer","year":"2014","unstructured":"Moyer VA. Screening for lung cancer: US preventive services task force recommendation statement. Ann Intern Med. 2014;160(5):330\u20138.","journal-title":"Ann Intern Med"},{"issue":"2","key":"469_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3322\/caac.21172","volume":"63","author":"R Wender","year":"2013","unstructured":"Wender R, Fontham ET, Barrera E Jr, Colditz GA, Church TR, Ettinger DS, Etzioni R, Flowers CR, Scott Gazelle G, Kelsey DK. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63(2):106\u201317.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"469_CR4","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.201508-1671ST","volume":"192","author":"RS Wiener","year":"2015","unstructured":"Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE. An official American Thoracic Society\/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015;192(7):881\u201391.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"469_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.chest.2016.05.006","volume":"150","author":"VS Nair","year":"2016","unstructured":"Nair VS, Sundaram V, Gould MK, Desai M. Use of [18F] Fluoro-2-deoxy-d-glucose positron emission tomographic imaging in the National Lung Screening Trial. Chest. 2016;150(3):621\u201330.","journal-title":"Chest"},{"issue":"1","key":"469_CR6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00330-014-3396-2","volume":"25","author":"G Soardi","year":"2015","unstructured":"Soardi G, Perandini S, Motton M, Montemezzi S. Assessing probability of malignancy in solid solitary pulmonary nodules with a new Bayesian calculator: improving diagnostic accuracy by means of expanded and updated features. Eur Radiol. 2015;25(1):155\u201362.","journal-title":"Eur Radiol"},{"issue":"5","key":"469_CR7","doi-asserted-by":"publisher","first-page":"e93S","DOI":"10.1378\/chest.12-2351","volume":"143","author":"MK Gould","year":"2013","unstructured":"Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS. Evaluation of individuals with pulmonary nodules: when is it lung cancer?: diagnosis and management of lung cancer: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5):e93S\u2013e120S.","journal-title":"Chest"},{"issue":"1","key":"469_CR8","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1148\/radiol.2017161659","volume":"284","author":"H MacMahon","year":"2017","unstructured":"MacMahon H, Naidich DP, Goo JM, Lee KS, Leung AN, Mayo JR, Mehta AC, Ohno Y, Powell CA, Prokop M. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner society 2017. Radiology. 2017;284(1):228\u201343.","journal-title":"Radiology"},{"issue":"6","key":"469_CR9","doi-asserted-by":"publisher","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","volume":"11","author":"DS Ettinger","year":"2013","unstructured":"Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'amico TA, Demmy TL, Govindan R, Grannis FW. Non\u2013small cell lung cancer, version 2.2013. J Natl Compr Cancer Netw. 2013;11(6):645\u201353.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7","key":"469_CR10","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.285.7.914","volume":"285","author":"MK Gould","year":"2001","unstructured":"Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. Jama. 2001;285(7):914\u201324.","journal-title":"Jama"},{"issue":"9315","key":"469_CR11","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(02)08352-6","volume":"359","author":"H van Tinteren","year":"2002","unstructured":"van Tinteren H, Hoekstra OS, Smit EF, van den Bergh JH, Schreurs AJ, Stallaert RA, van Velthoven PC, Comans EF, Diepenhorst FW, Verboom P. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet. 2002;359(9315):1388\u201392.","journal-title":"Lancet"},{"issue":"3","key":"469_CR12","doi-asserted-by":"publisher","first-page":"94S","DOI":"10.1378\/chest.07-1352","volume":"132","author":"MM Wahidi","year":"2007","unstructured":"Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines. Chest. 2007;132(3):94S\u2013107S.","journal-title":"Chest"},{"key":"469_CR13","doi-asserted-by":"publisher","first-page":"9719067","DOI":"10.1155\/2019\/9719067","volume":"2019","author":"C Leung","year":"2019","unstructured":"Leung C, Shaipanich T. Current practice in the Management of Pulmonary Nodules Detected on computed tomography chest scans. Can Respir J. 2019;2019:9719067. https:\/\/doi.org\/10.1155\/2019\/9719067.","journal-title":"Can Respir J"},{"key":"469_CR14","doi-asserted-by":"publisher","first-page":"j347","DOI":"10.1136\/bmj.j347","volume":"356","author":"C Rampinelli","year":"2017","unstructured":"Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, Spaggiari L, Bellomi M. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017;356:j347. https:\/\/doi.org\/10.1136\/bmj.j347.","journal-title":"BMJ"},{"issue":"7","key":"469_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1097\/JTO.0b013e31828f68d6","volume":"8","author":"A Lopes Pegna","year":"2013","unstructured":"Lopes Pegna A, Picozzi G, Falaschi F, Carrozzi L, Falchini M, Carozzi FM, Pistelli F, Comin C, Deliperi A, Grazzini M, Innocenti F, Maddau C, Vella A, Vaggelli L, Paci E, Mascalchi M, Group ISR. Four-year results of low-dose CT screening and nodule management in the ITALUNG trial. J Thorac Oncol. 2013;8(7):866\u201375. https:\/\/doi.org\/10.1097\/JTO.0b013e31828f68d6.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"469_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2967\/jnmt.108.059584","volume":"38","author":"AK Buck","year":"2010","unstructured":"Buck AK, Herrmann K, Stargardt T, Dechow T, Krause BJ, Schrey\u00f6gg J. Economic evaluation of PET and PET\/CT in oncology: evidence and methodologic approaches. J Nucl Med Technol. 2010;38(1):6\u201317.","journal-title":"J Nucl Med Technol"},{"issue":"6","key":"469_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1513\/AnnalsATS.201305-107OC","volume":"10","author":"AA Balekian","year":"2013","unstructured":"Balekian AA, Silvestri GA, Simkovich SM, Mestaz PJ, Sanders GD, Daniel J, Porcel J, Gould MK. Accuracy of clinicians and models for estimating the probability that a pulmonary nodule is malignant. Ann Am Thorac Soc. 2013;10(6):629\u201335.","journal-title":"Ann Am Thorac Soc"},{"issue":"5","key":"469_CR18","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.2214\/ajr.170.5.9574618","volume":"170","author":"JJ Erasmus","year":"1998","unstructured":"Erasmus JJ, McAdams HP, Patz EF Jr, Coleman RE, Ahuja V, Goodman PC. Evaluation of primary pulmonary carcinoid tumors using FDG PET. AJR Am J Roentgenol. 1998;170(5):1369\u201373. https:\/\/doi.org\/10.2214\/ajr.170.5.9574618.","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"469_CR19","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1136\/thx.2010.136747","volume":"66","author":"H Ashraf","year":"2011","unstructured":"Ashraf H, Dirksen A, Loft A, Bertelsen AK, Bach KS, Hansen H, Pedersen JH, Mortensen J. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning. Thorax. 2011;66(4):315\u20139. https:\/\/doi.org\/10.1136\/thx.2010.136747.","journal-title":"Thorax"},{"issue":"10","key":"469_CR20","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1164\/rccm.201505-0990OC","volume":"192","author":"MK Gould","year":"2015","unstructured":"Gould MK, Tang T, Liu I-LA, Lee J, Zheng C, Danforth KN, Kosco AE, Di Fiore JL, Suh DE. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med. 2015;192(10):1208\u201314.","journal-title":"Am J Respir Crit Care Med"},{"key":"469_CR21","doi-asserted-by":"publisher","unstructured":"Huo J, Xu Y, Sheu T, Volk RJ, Shih YT. Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting. JAMA Intern Med. 2019. https:\/\/doi.org\/10.1001\/jamainternmed.2018.6277.","DOI":"10.1001\/jamainternmed.2018.6277"},{"issue":"6","key":"469_CR22","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s00259-009-1061-9","volume":"36","author":"O Kagna","year":"2009","unstructured":"Kagna O, Solomonov A, Keidar Z, Bar-Shalom R, Fruchter O, Yigla M, Israel O, Guralnik L. The value of FDG-PET\/CT in assessing single pulmonary nodules in patients at high risk of lung cancer. Eur J Nucl Med Mol Imaging. 2009;36(6):997\u20131004. https:\/\/doi.org\/10.1007\/s00259-009-1061-9.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"469_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3201\/eid2203.151117","volume":"22","author":"K Benedict","year":"2016","unstructured":"Benedict K, Mody RK. Epidemiology of Histoplasmosis outbreaks, United States, 1938-2013. Emerg Infect Dis. 2016 Mar;22(3):370\u20138. https:\/\/doi.org\/10.3201\/eid2203.151117.","journal-title":"Emerg Infect Dis"},{"key":"469_CR24","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.lungcan.2019.08.026","volume":"136","author":"S Bhandari","year":"2019","unstructured":"Bhandari S, Tripathi P, Pham D, Pinkston C, Kloecker G. Performance of community-based lung cancer screening program in a Histoplasma endemic region. Lung Cancer. 2019 Oct;136:102\u20134. https:\/\/doi.org\/10.1016\/j.lungcan.2019.08.026.","journal-title":"Lung Cancer"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-020-00469-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-020-00469-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T19:44:08Z","timestamp":1624304648000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-020-00469-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["469"],"URL":"https:\/\/doi.org\/10.1186\/s12880-020-00469-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21901\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21901\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21901\/v3","asserted-by":"object"}]},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"20 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the institutional review boards of WVU (Protocol Number: 1805111017). Retrospective chart review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no financial or non-financial competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}